MADRIGAL PHARMACEUTICALS, INC. |
Director |
Common Stock |
1.91K |
$688K |
$360.07 |
Feb 27, 2025 |
Direct |
Epizyme, Inc. |
Director |
Stock Option (Right to Buy) |
41K |
$23K |
$0.56 |
May 17, 2022 |
Direct |
AVEO PHARMACEUTICALS, INC. |
Director |
Common Stock |
375 |
$5.63K |
$15.00 |
Jan 19, 2023 |
Direct |
GENOCEA BIOSCIENCES, INC. |
Director |
Stock Option (Right to Buy) |
15K |
|
|
Jul 1, 2021 |
Direct |
Astria Therapeutics, Inc. |
Director |
Stock Option (Right to Buy) |
14.1K |
|
|
Jun 5, 2024 |
Direct |
MADRIGAL PHARMACEUTICALS, INC. |
Director |
Stock Option (Right to Buy) |
5.47K |
|
|
Feb 27, 2025 |
Direct |
AVEO PHARMACEUTICALS, INC. |
Director |
Stock Option (Right to Buy) |
0 |
|
|
Jan 19, 2023 |
Direct |
Epizyme, Inc. |
Director |
Common Stock, par value $0.0001 |
0 |
|
$1.41 |
Aug 12, 2022 |
Direct |